We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Genetic Biomarkers in Feces Predict Colon Cancer

By LabMedica International staff writers
Posted on 09 Mar 2011
Biomarkers that predicted inflammation-associated colon cancer were found in mouse feces. This is the same type of cancer associated with some common human inflammatory bowel diseases such as ulcerative colitis and Crohn's Disease.

Scientists found that the bacterium that leads to inflammation-associated colon cancer in mice first results in inflammation that can be detected by screening feces for messenger RNA of genes.

Craig Franklin, associate professor of veterinary pathobiology in the University of Missouri (MU) College of Veterinary Medicine (Columbia, MO, USA), believes that this discovery could lead to tests for similar genes present in humans with early inflammation-associated colon cancer. The study was published in the December 2010 edition of the journal Neoplasia.

"The assumption was that the gene expression couldn't be detected in fecal matter because RNA breaks down very rapidly. Historically, this was something that a lot of scientists, including us, hadn't considered," Prof. Franklin said. "But technology has evolved, and we now have the means of preserving RNA much better than we did 15 years ago."

The new testing method should decrease the number of animals needed for research and could lead to a test for humans that will replace colonoscopies.

Related Links:

University of Missouri College of Veterinary Medicine




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10

Latest Molecular Diagnostics News

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation
09 Mar 2011  |   Molecular Diagnostics

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth
09 Mar 2011  |   Molecular Diagnostics

Liquid Biopsy Combines Multiple Signals for Cancer Detection in a Single Analysis
09 Mar 2011  |   Molecular Diagnostics